Home » Stocks » Twist Bioscience

Twist Bioscience Corporation (TWST)

Stock Price: $85.97 USD -1.09 (-1.25%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
After-hours: $85.99 +0.02 (0.02%) Oct 23, 5:56 PM

Stock Price Chart

Key Info

Market Cap 3.84B
Revenue (ttm) 73.41M
Net Income (ttm) -146.79M
Shares Out 44.66M
EPS (ttm) -4.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $85.97
Previous Close $87.06
Change ($) -1.09
Change (%) -1.25%
Day's Open 87.24
Day's Range 85.09 - 91.35
Day's Volume 581,659
52-Week Range 18.52 - 100.30

More Stats

Market Cap 3.84B
Enterprise Value 3.57B
Earnings Date (est) Dec 16, 2020
Ex-Dividend Date n/a
Shares Outstanding 44.66M
Float 32.23M
EPS (basic) -4.16
EPS (diluted) -4.05
FCF / Share -3.63
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 4.35M
Short Ratio 6.86
Short % of Float 13.49%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 52.31
PB Ratio 11.14
Revenue 73.41M
Operating Income -147.68M
Net Income -146.79M
Free Cash Flow -151.93M
Net Cash 273.84M
Net Cash / Share 6.13
Gross Margin 9.48%
Operating Margin -201.19%
Profit Margin -200.00%
FCF Margin -206.98%
ROA -25.44%
ROE -55.93%
ROIC -94.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 2
Overweight 1
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(-6.36% downside)
Current: $85.97
Target: 80.50
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth113.89%136.16%374.53%-
Gross Profit6.96-6.76-13.25-7.15
Operating Income-109-70.56-58.48-43.66
Net Income-108-71.24-59.31-44.09
Shares Outstanding27.462.792.421.87
Earnings Per Share-3.92-25.51-24.49-23.58
Operating Cash Flow-87.94-66.16-51.30-38.59
Capital Expenditures-14.74-3.67-6.33-6.23
Free Cash Flow-103-69.84-57.63-44.82
Cash & Equivalents13880.7662.2055.92
Total Debt7.739.729.1511.18
Net Cash / Debt13071.0453.0544.74
Book Value152-201-133-76.61
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Twist Bioscience Corporation
Country United States
Employees 414
CEO Emily Marine Leproust

Stock Information

Ticker Symbol TWST
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: TWST
IPO Date October 31, 2018


Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has collaboration agreements with Pandion Therapeutics, Inc. and Schrödinger Inc. It also has a partnership with Serimmune Inc. to identify and evaluate SARS-CoV-2 therapeutic antibody candidates. The company was founded in 2013 and is headquartered in South San Francisco, California.